Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Reports on Amag

Sort by

AMAG Pharmaceuticals: Will FDA Approve Makena SC (AMAG, Neutral, $21.75)

Friday, February 3, 2017 · 10:15 am

Read More

AMAG and Antares: Update on the Development of Makena SC (AMAG, Neutral, $24.40) (ATRS, Buy, $2.04)

Thursday, January 26, 2017 · 9:44 am

Read More

AMAG Pharmaceuticals: Initiation of Research on a Complex but Potentially Very Interesting Investment Situation (AMAG, Neutral, $24)

Sunday, June 26, 2016 · 9:11 am

Read More

There are 3 reports on file.

« Back to Company Reports Index